Results for polimorfiskais translation from Latvian to Czech

Computer translation

Trying to learn how to translate from the human translation examples.

Latvian

Czech

Info

Latvian

polimorfiskais

Czech

 

From: Machine Translation
Suggest a better translation
Quality:

Human contributions

From professional translators, enterprises, web pages and freely available translation repositories.

Add a translation

Latvian

Czech

Info

Latvian

fluoksetīnu plaši metabolizē polimorfiskais enzīms cyp2d6.

Czech

fluoxetin je extenzivně metabolizován polymorfním enzymem cyp2d6.

Last Update: 2012-04-10
Usage Frequency: 2
Quality:

Latvian

duloksetīnu ekstensīvi metabolizē oksidatīvi enzīmi (cyp1a2 un polimorfiskais cyp2d6), kam seko konjugācija.

Czech

je extenzívně metabolizován oxidačními enzymy (cyp1a2 a polymorfní cyp2d6) a následně konjugován.

Last Update: 2012-04-10
Usage Frequency: 2
Quality:

Latvian

duloksetīnu ekstensīvi metabolizē oksidatīvie enzīmi (cyp1a2 un polimorfiskais cyp2d6), pēc tam notiek konjugācija.

Czech

duloxetin je ve velké míře metabolizován oxidačními enzymy (cyp1a2 a polymorfním cyp2d6) s následnou konjugací.

Last Update: 2012-04-10
Usage Frequency: 2
Quality:

Latvian

nozīmīgākā oksidētā metabolīta m8 (tertbutilhidroksinelfinavira) in vitro pretvīrusu aktivitāte bija līdzīga nemainītām zālēm, un tā veidošanos katalizē polimorfiskais citohroms cyp2c19.

Czech

tvorba m8 je katalyzována polymorfním cytochromem cyp2c19.

Last Update: 2011-10-23
Usage Frequency: 1
Quality:

Warning: This alignment may be wrong.
Please delete it you feel so.

Latvian

pētījumi in vitro liecina, ka polimorfiskiem enzīmiem cyp2c9, cyp2d6 un cyp2c19 nav lielas nozīmes maraviroka metabolismā.

Czech

in vitro studie také naznačují, že polymorfní enzymy cyp2c9, cyp2d6 a cyp2c19 se významně nepodílejí na metabolismu maraviroku.

Last Update: 2012-04-10
Usage Frequency: 2
Quality:

Get a better translation with
7,749,195,517 human contributions

Users are now asking for help:



We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. Learn more. OK